22.05.2022 Views

DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

mucosa, producing higher cocaine levels in the blood and a more

rapid onset of stimulation. Subsequently, it was found that a solution

of cocaine hydrochloride could be administered intravenously,

giving a more rapid onset of stimulatory effects. Each newly available

cocaine preparation that provided greater speed of onset and an

increment in blood level was paralleled by a greater likelihood of

addiction. In the 1980s, the availability of cocaine to the American

public was increased further with the invention of crack cocaine.

Crack, sold illegally and at a low price ($1-3 per dose), is alkaloidal

cocaine (free base), which can be readily vaporized by heating.

Simply inhaling the vapors produces blood levels comparable to

those resulting from intravenous cocaine owing to the large surface

area for absorption into the pulmonary circulation following inhalation.

The cocaine-containing blood then enters the left side of the

heart and reaches the cerebral circulation without dilution by the systemic

circulation. Thus, inhalation of crack cocaine is much more

addictive than chewing, drinking, or sniffing cocaine. Inhalation,

with rapid attainment of effective drug levels in the brain, also is the

preferred route for users of nicotine and cannabis.

Although the drug variables are important, they

do not fully explain the development of addiction. Most

people who experiment with drugs of high addictive

potential (addiction liability) do not intensify their drug

use and lose control. The risk for developing addiction

among those who try nicotine is about twice that for

those who try cocaine (Table 24–2). This does not

imply that the pharmacological addiction liability of

Table 24–2

Dependence among Users 1990–1992

EVER

RISK OF

USED ∗ ADDICTION ADDICTION

AGENT % % %

Tobacco 75.6 24.1 31.9

Alcohol 91.5 14.1 15.4

Illicit drugs 51.0 7.5 14.7

Cannabis 46.3 4.2 9.1

Cocaine 16.2 2.7 16.7

Stimulants 15.3 1.7 11.2

Anxiolytics 12.7 1.2 9.2

Analgesics 9.7 0.7 7.5

Psychedelics 10.6 0.5 4.9

Heroin 1.5 0.4 23.1

Inhalants 6.8 0.3 3.7

*The ever-used and addiction percentages are those of the general

population. The risk of addiction is specific to the drug indicated and

refers to the percentage who met criteria for addiction among those

who reported having used the agent at least once (i.e., each value in

column 4 was obtained by expressing the number in column 3 as a

percentage of the number in column 2, subject to errors of rounding).

Source: Anthony et al., 1994.

nicotine is twice that of cocaine. Rather, there are other

variables listed in the categories of host factors and

environmental conditions that influence the development

of addiction.

Host (User) Variables. In general, effects of drugs vary

among individuals. Even blood levels can show wide variation

when the same dose of a drug on a milligram-perkilogram

basis is given to different people. Polymorphism

of genes that encode enzymes involved in absorption,

metabolism, and excretion and in receptor-mediated

responses may contribute to the different degrees of reinforcement

or euphoria observed among individuals

(Chapters 6 and 7).

Children of alcoholics show an increased likelihood of developing

alcoholism, even when adopted at birth and raised by nonalcoholic

parents. The studies of genetic influences in this disorder

show only an increased risk for developing alcoholism, not a 100%

determinism, consistent with a polygenic disorder that has multiple

determinants. Even identical twins, who share the same genetic

endowment, do not have 100% concordance when one twin is alcoholic.

However, the concordance rate for identical twins is much

higher than that for fraternal twins. The abuse of alcohol and other

drugs tends to have some familial characteristics, suggesting that

common mechanisms may be involved.

Innate tolerance to alcohol as measured by level of response

to alcohol administered under experimental conditions may represent

a biological trait that contributes to the development of alcoholism

(Chapter 23). While innate tolerance increases vulnerability to alcoholism,

impaired metabolism may protect against it. See Chapter 23

for a discussion of the genetic variation common in Asian populations

that results in facial flushing and reduced alcohol intake or no

alcohol intake in those homozygous for the gene variant. Similarly,

individuals who inherit a gene associated with slow nicotine metabolism

may experience unpleasant effects when beginning to smoke

and reportedly have a lower probability of becoming nicotine

dependent.

Psychiatric disorders constitute another category of host variables.

Drugs may produce immediate, subjective effects that relieve

preexisting symptoms. People with anxiety, depression, insomnia,

or even subtle symptoms such as shyness may find, on experimentation

or by accident, that certain drugs give them relief. However,

the apparent beneficial effects are transient, and repeated use of the

drug may lead to tolerance and eventually compulsive, uncontrolled

drug use. While psychiatric symptoms are seen commonly in drug

abusers presenting for treatment, most of these symptoms begin after

the person starts abusing drugs. Thus, drugs of abuse appear to produce

more psychiatric symptoms than they relieve.

Environmental Variables. Initiating and continuing illegal

drug use appear to be influenced significantly by

societal norms and peer pressure. Taking drugs may be

seen initially as a form of rebellion against authority. In

some communities, drug users and drug dealers are

role models who seem to be successful and respected;

thus, young people emulate them. There also may be a

651

CHAPTER 24

DRUG ADDICTION

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!